76 CHAPTER 2.2 References 1. Grol R, Grimshaw J. From best evidence to best practice: Effective implementation of change in patients’ care. Lancet. 2003; 362:1225–30. 2. Michie S. Changing clinical behaviour by making guidelines specific. BMJ. 2004;328:343-5 3. Van Munster BC, Portielje JEA, Maier AB, Arends AJ, de Beer JJA. Methodology for senior-proof guidelines: A practice example from the Netherlands. J Eval Clin Pract. 2018;24(1):254–7. 4. Mutasingwa DR, Ge H, Upshur REG. How applicable are clinical practice guidelines to elderly patients with comorbidities? Canadian Family Physician. 2011;57:253-62. 5. Beers E, Egberts TCG, Leufkens HGM, Jansen PAF. Information for adequate prescribing to older patients: An evaluation of the product information of 53 recently approved medicines. Drugs and Aging. 2013;30(4):255–62. 6. Howard RL, Avery AJ, Slavenburg S et al. Which drugs cause preventable admissions to hospital? A systematic review. Br J Clin Pharmacol. 2007;63(2):136–47. 7. Leendertse AJ, Egberts ACG, Stoker LJ, Van Den Bemt PMLA. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med. 2008;168(17):1890–6. 8. Lavan AH, Gallagher PF, O’Mahony D. Methods to reduce prescribing errors in elderly patients with multimorbidity. Clin Interv Aging. 2016;11:857–66. 9. Page RL, Linnebur SA, Bryant LL, Ruscin JM. Inappropriate prescribing in the hospitalized elderly patient: Defining the problem, evaluation tools, and possible solutions. Clin Interv Aging. 2010;5(1):75–87. 10. American Geriatrics Society 2019 Expert Panel. American Geriatrics Society 2019 Updated AGS Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc. 2019;67(4):674–94. 11. Mangin D, Bahat G, Golomb BA et al. International Group for Reducing Inappropriate Medication Use & Polypharmacy (IGRIMUP): Position Statement and 10 Recommendations for Action. Drugs and Aging. 2018;35(7):575–87. 12. Gallagher P, Lang PO, Cherubini A et al. Prevalence of potentially inappropriate prescribing in an acutely ill population of older patients admitted to six European hospitals. Eur J Clin Pharmacol. 2011;67(11):1175–88. 13. Galvin R, Moriarty F, Cousins G et al. Prevalence of potentially inappropriate prescribing and prescribing omissions in older Irish adults: Findings from the Irish LongituDinal Study on Ageing study (TILDA). Eur J Clin Pharmacol. 2014;70(5):599–606. 14. Di Giorgio C, Provenzani A, Polidori P. Potentially inappropriate drug prescribing in elderly hospitalized patients: an analysis and comparison of explicit criteria. Int J Clin Pharm. 2016;38(2):462–8. 15. Ryan C, O’Mahony D, Byrne S. Application of STOPP and START criteria: Interrater reliability among pharmacists. Ann Pharmacother. 2009;43(7–8):1239–44. 16. Gallagher, P, Baeyens JP, Topinkova E et al. Inter-rater reliability of STOPP (Screening Tool of Older Persons’ Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment) criteria amongst physicians in six European countries. Age Ageing. 2009;38(5):603–5. 17. O’Mahony D, O’sullivan D, Byrne S, O’connor MN, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: Version 2. Age Ageing. 2015;44(2):213–8.